Drug information provided by: Merative, Micromedex®
Burosumab-twza injection is used to treat X-linked hypophosphatemia (low phosphate levels in the blood). This medicine is also used to treat FGF23-related hypophosphatemia in patients with tumor-induced osteomalacia (soft bones) whose tumors are limited to a certain part of the body and cannot be removed by surgery.
This medicine should be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2023
Copyright: © Merative US L.P. 1973, 2023. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.